Relationship between Federal and State Funding for Breast Cancer Research

The California Breast Cancer Research Program is distinct from research programs funded by the federal government in both the CBCRP’s sources of funding and in the types of research funded.

The CBCRP’s Source of Funding: Unique Among The Nation’s Breast Cancer Research Agencies
The primary source of funding for the CBCRP is a 45 percent share of revenue from a two-cent State tax on cigarettes. This source of funding is unique among agencies that fund breast cancer research across the nation.

In contrast, funding for breast cancer research at other programs in the U.S. comes from a variety of different sources:

The California Breast Cancer Research Program’s primary source of funds, from a State tax on cigarettes, is declining and temporary. In the past, measures were proposed in the California State Legislature that would have had the indirect effect of decreasing funding for the CBCRP by $5 million; similar measures may be proposed, and may pass, in the future.

The CBCRP also receives some funding from the income tax check-off program, which allows individuals the opportunity to make voluntary donations on state income tax returns. Voluntary tax contribution funding is a result of legislation passed by the California State Legislature that authorizes donations for five years. During 2007, AB28, a bill authored by Assembly Member Jared Huffman, became law. This legislation provides individuals the opportunity to make donations to the CBCRP through voluntary tax contributions through 2012.

To increase these sources of revenue, the CBCRP conducts a public outreach and fundraising effort, the Community Partners Program. This effort, begun in 2002, has led to an increase in donations to the CBCRP from individuals, businesses, and foundations. The CBCRP’s Community Partners Program is discussed more fully in the section of this report titled “Increasing Funding for and Awareness of Breast Cancer Research.”

Types of Research Funded by the CBCRP: Complementing, Not Duplicating, Federal Efforts
The CBCRP has a deep commitment to using the funds provided by the State of California in the most efficient and cost-effective manner, and to adhering to the Program’s mandate as defined by the California Legislature. One of the CBCRP’s mandates is to “fund innovative and creative research, with a special emphasis on research that complements, rather than duplicates, the research funded by the federal government.” The CBCRP fulfills this mandate in three ways:

  1. By funding breast cancer research areas that could have a major impact on breast cancer— including leading to prevention and cure—that are not getting sufficient attention from the federal government;
  2. By having expert reviewers from across the U.S. review grant applications for their innovation and impact;
  3. Before funding a grant application, reviewing it for overlap with current and pending funding from other agencies;
  4. By taking leadership to reduce barriers and waste in state, federal, and international breast cancer research funding.

Funding Promising Areas of Research That Have Not Received Sufficient Attention
The federal government’s method for funding research has led to some promising areas of breast cancer research being under-funded. The federal government funds most health-related research through the National Institutes of Health (NIH). The NIH view is on “capitalizing…investigator-initiated research.” The primary basis on which the NIH chooses grants for funding is their scientific merit, not their relevance to a particular disease. As a result, most research proposals submitted to the NIH address scientific questions in which the investigators have theoretical and empirical interest, even though there may be no clear relevance to particular diseases.

Only a small percentage of NIH funds go to research in issues the NIH has identified as particularly important to specified diseases (i.e., Requests for Applications). The majority of NIH funds support the most scientifically meritorious research regardless of the applicability of the research to particular diseases.

In contrast, a fundamental priority for the CBCRP is to fund research that will speed progress in preventing and curing breast cancer. The CBCRP’s advisory Breast Cancer Research Council sets the Program’s funding priorities, taking into account:

The council attempts to identify and fill important gaps in knowledge about breast cancer and reviews priorities yearly in light of changes in the research field, successes and failures of previous funding initiatives, and the results of previous funding. The CBCRP is conducting a program initiative begun in 2005 to fill a significant gap in breast cancer research. The Special Research Initiatives addresses three overlapping research questions that California is uniquely positioned to address. They are environmental links to breast cancer, the reasons for the unequal burden of breast cancer among various populations of women, and the intersections of multiple factors that impact breast cancer. More information on these Special Research Initiatives may be found in a previous section of this report, “The CBCRP Strategy for Allocating Research Funds.”

Choosing Research for Innovation and Impact
The CBCRP created its own scoring system to allow the Program’s expert reviewers to differentiate applications that are especially innovative and that have the most potential impact on breast cancer. The scoring system has improved the Program’s ability to choose the most innovative and creative research for funding.

In the past, the majority of research funding agencies, including the CBCRP and the National Institutes of Health, scored funding proposals with a single score based solely on scientific merit. With this method, an application with an excellent research plan to test an idea that wasn’t particularly novel could receive the same score as an application with a flawed research plan to test a novel idea. The CBCRP’s scoring method, based on the recommendations of an NIH Advisory Committee, can distinguish these two applications. The CBCRP scores applications separately for innovation, impact, approach, and feasibility. The CBCRP’s advisory Breast Cancer Research Council uses these separate scores to inform their funding recommendations. Under the CBCRP’s “impact” criterion, researchers are required to describe the steps necessary to turn their research into products, technologies, or interventions that will have an impact on breast cancer, and describe where their study fits into this critical path.

Reviewing Grant Proposals for Overlap with Federal Funding
As a final step to ensure that CBCRP-funded research doesn’t duplicate federally-funded research, breast cancer science experts in other states and Program staff scientists review all grants recommended for funding for overlap with current and pending federal grants. If overlap with federal funding is found, the overlapping grant (or portion of the grant) is not funded.

Taking Leadership to Reduce Barriers and Waste In Federal, State, and International Funding
The CBCRP is part of a nationwide effort to reduce barriers and waste in research toward the goal of ending breast cancer. Along with other U.S. breast cancer research funding agencies, industry representatives, regulators, advocates, and social scientists, the CBCRP participates in the National Breast Cancer Planning Committee, which is reviewing the national breast cancer research agenda and assisting U.S. breast cancer organizations in identifying gaps, opportunities, and overlaps in research into the disease. The committee will also produce a report to the general public on how key breast cancer organizations use donations to fund research.

In addition, the CBCRP has joined with seven other cancer research funding organizations in the U.S., 15 of the largest government and charitable cancer research funders in the United Kingdom, and the key government and nongovernment cancer research funders in Canada in the International Cancer Research Portfolio (ICRP). The organizations that make up the ICRP are working to make it easier to avoid duplication among research funding agencies and to speed progress in breast cancer research by increasing communication among agencies that fund breast cancer research.

One way the ICRP pursues these goals is by developing a research classification system to encourage agencies to report their funding in a way that is more accessible and meaningful to other agencies and the public. The ICRP also has a Web site (www.cancerportfolio.org) that includes research abstracts from more than 14,000 current and past research projects. The online database is searchable by cancer type, scientific area, funding organization, and other selected criteria. The Web site allows scientists to identify possible collaborators, plan their research based on current research, and facilitate dialogues among cancer researchers. Access to this information about ongoing research also aids research funding organizations in strategic planning for future spending. In addition, the Web site is a useful tool for other groups. Policy makers may use the database during the formulation of new health care and service delivery policies. Healthcare professionals, patients, survivors, and advocates may review the current status of funded research.

The CBCRP and the Program’s partners in this effort are dedicated to making current research information available to funding agencies and the public, and to promoting scientific collaboration. To extend coordination further, the ICRP partners invite representatives from the other organizations to attend their scientific meetings and review in person their funded research. During 2008, the ICRP took international coordination to a higher level by conducting an evaluation of the career development funding trends in the U.S. and U.K. In 2009, the ICRP will publish a review of cancer research funding patterns in the U.S., U.K., and Canada that will point to gaps in research and make recommendations for research priorities to fill those gaps.